NCT05156138

Brief Summary

The study aims to compare the endothelial cell count in patients with pseudoexfoliation syndrome to the the endothelial cell count in normal patients above the age of 50.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 25, 2021

Completed
19 days until next milestone

First Posted

Study publicly available on registry

December 14, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

January 24, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 24, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 24, 2022

Completed
Last Updated

December 14, 2021

Status Verified

December 1, 2021

Enrollment Period

6 months

First QC Date

November 25, 2021

Last Update Submit

December 8, 2021

Conditions

Keywords

Pseudoexfoliation syndromeCorneal endothelial count

Outcome Measures

Primary Outcomes (1)

  • to determine the possible association between pseudoexfoliation syndrome and corneal endothelial cell changes by measuring:

    1. Endothelial cell density by specular microscopy to be categorized qualitatively into one of two groups (normal/abnormal cell count): A. A group with normal cell count (2100-3200 cells/mm2) B. A group with low or abnormal cell count (less than the previous range). 2. Pseudoexfoliation presence: to qualitatively categorize patients into one of two groups (pseudoexfoliation/ No pseudoexfoliation)

    one year

Secondary Outcomes (1)

  • Endothelial cell morphology: to qualitatively categorize the patient subjectively into normal and abnormal shape using specular microscopy.

    one year

Study Arms (2)

study group

patients with pseudoexfoliation fulfilling the inclusion criteria

Other: no interventions as it is a case control observational study

control group

patients without pseudoexfoliation fulfilling the inclusion criteria

Other: no interventions as it is a case control observational study

Interventions

no interventions as it is a case control observational study

control groupstudy group

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients above the age of 50 at the outpatient clinic

You may qualify if:

  • \- Pesudoexfoliation Egyptian patients and controls groups must be at least 50 years old and matched from age.
  • Controls will be selected from the same outpatient clinic.

You may not qualify if:

  • Patients with history of previous intraocular surgeries, wearing contact lens and endothelial dystrophies.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assuit university

Asyut, 71511, Egypt

RECRUITING

MeSH Terms

Conditions

Exfoliation Syndrome

Condition Hierarchy (Ancestors)

Iris DiseasesUveal DiseasesEye Diseases

Central Study Contacts

Ali Alhussaini, mbbch

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 25, 2021

First Posted

December 14, 2021

Study Start

January 24, 2022

Primary Completion

July 24, 2022

Study Completion

September 24, 2022

Last Updated

December 14, 2021

Record last verified: 2021-12

Locations